Stifel raises Illumina stock price target to $225 on strong demand
What it means
- What to watch: $ILMN saw its price target move toward $225 — targets follow prices about as often as they lead them.
- How the stock is trading: $ILMN +0.44% in the latest session.
- Timing: It landed during trading hours — the market got to read it live, so the session move beside it may already carry the reaction.
Where the stock stands
$ILMN last changed hands at $290.06, +0.44% on the session, 6.2% below its 52-week high of $309.35 and 209% above its low of $94.00 — within a tenth of its 52-week high. Over the year it has ranged 229% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $ILMN page.
How much coverage it is getting
Nothing else on $ILMN in the last 30 days: this is the only story Wook has filed, so there is no run to measure it against yet. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
What to watch next
For the receipts, the $ILMN page has the full chart, the filings and the valuation model these figures come from. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. And Wook AI, up top, will happily do the math — how far $ILMN sits from its high, or how this week's coverage stacks up.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. It reads bullish at medium severity because of “strong” in the wording, with nothing on the bearish side to offset it. It was matched to $ILMN. It carried $225, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on July 31, 2026. $ILMN has moved +46.38% ($198.16 to $290.06). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.